A carregar...

Tyrosine Kinase Inhibitors (TKI) in Leukemia and Cardiovascular events - From mechanism to patient care

Targeted oncology therapies have revolutionized cancer treatment over the last decade and have resulted in improved prognosis for many patients. This advance has emanated from elucidation of pathways responsible for tumorigenesis followed by targeting of these pathways by specific molecules. Cardiov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arterioscler Thromb Vasc Biol
Main Authors: Manouchehri, Ali, Kanu, Elishama, Mauro, Michael J., Aday, Aaron W., Lindner, Jonathan R., Moslehi, Javid
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993877/
https://ncbi.nlm.nih.gov/pubmed/31875699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.119.313353
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!